Search
Tandem Diabetes Care Inc
TNDMAdd to Watchlist
15.300USD
-0.100-0.65%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.05BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Tandem Diabetes Care Inc is 7.33, ranking 140 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 18.00, with a high of 55.00 and a low of 14.00.
Analyst Rating
Based on
23
analysts
Buy
Current Rating
29.579
Target Price
+93.33%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Tandem Diabetes Care Inc
TNDM
23
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Tandem Diabetes Care Inc's expected revenue for the next quarter?
Tandem Diabetes Care Inc's expected revenue is 255.20M.
What is Tandem Diabetes Care Inc's price target?
Analysts forecast that Tandem Diabetes Care Inc's price target is USD 18.00, with the highest forecast at USD 55.00 and the lowest forecast at USD 14.00.
How have Tandem Diabetes Care IncTNDM's recent earnings per share performed?
The market expectation was USD -0.30, while Tandem Diabetes Care IncTNDM's earnings per share (EPS) for the previous quarter was USD -0.01. EPS for the next quarter is expected at USD -0.33.
What is the analyst rating for Tandem Diabetes Care Inc?
Based on the ratings of Tandem Diabetes Care Inc's stock from 23 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
